Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPSC generation for genetic neurodevelopmental disorders
NL-OMON44331Completed
- Sponsor
- Erasmus MC
- Start
- Oct 2017
- Countries
- 1
01
Overview
Open-label trial of induced pluripotent stem cells in Genetic neurodevelopmental disorders (GND) and Neurodevelopmental disorder (NDD) (2 arms), sponsored by Erasmus MC. Started Oct 2017; status: completed.
02
Drugs
induced pluripotent stem cells
03
Conditions
Genetic neurodevelopmental disorders (GND)Neurodevelopmental disorder (NDD)
Beyond the preview
Go deeper on NL-OMON44331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44331.